TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,480,784 | -17.0% | 1,612,534 | +146.7% | 0.07% | -14.3% |
| Q2 2023 | $16,234,927 | -11.0% | 653,580 | -46.1% | 0.08% | -15.4% |
| Q1 2023 | $18,251,627 | +30.8% | 1,213,539 | +2.9% | 0.09% | +16.7% |
| Q4 2022 | $13,953,166 | +193.0% | 1,179,473 | +46.6% | 0.08% | +200.0% |
| Q3 2022 | $4,762,000 | +26.7% | 804,369 | -9.0% | 0.03% | +36.8% |
| Q2 2022 | $3,758,000 | -64.9% | 884,316 | -21.4% | 0.02% | -68.9% |
| Q1 2022 | $10,702,000 | +23.2% | 1,125,323 | +146.2% | 0.06% | +27.1% |
| Q4 2021 | $8,685,000 | +299.3% | 457,126 | +993.2% | 0.05% | +166.7% |
| Q4 2020 | $2,175,000 | +534.1% | 41,814 | +20.0% | 0.02% | +80.0% |
| Q1 2020 | $343,000 | +36.7% | 34,846 | +54.4% | 0.01% | +100.0% |
| Q4 2019 | $251,000 | – | 22,569 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |